ALOPM fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Oncodesign Precision Medicine (OPM) SAS manufactures precision medicine. It has built a unique precision medicine platform dedicated to cancerous diseases and other diseases without therapeutic solution. Its innovative platform for the selection of new therapeutic targets has been developed on the basis of patient data and through a novel approach using Artificial Intelligence. The company was founded on December 15, 2020 and is headquartered in Dijon, France.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
ALOPM does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company